
Alejandro Luna
@thelunar_a
H. Ramón y Cajal. Madrid 🇪🇸 Hematology. Int: BMT/cell therapy, NK cells and 🍕. Currently visiting at @MSKCancerCenter ‘23-‘24
ID: 1366886303401472003
02-03-2021 23:01:15
244 Tweet
394 Followers
1,1K Following




Happy to share our latest work! Reducing PT-Cy total dose to 80 mg/kg is a safe and valid approach in elderly patients with hematological malignancies undergoing haploidentical PBSC transplantation. ARTICLE 👉 nature.com/articles/s4140… Cc Mohamad Mohty Florent Malard #BMTsm #PTCy



One of the most impressive T cell papers in the past decades. A truly humbling experiment and incredibly important insights into T cell biology. Masopust Vezys Lab truly amazing. A must read for all T cell biologist (all immunologists really). #instantclassic nature.com/articles/s4158…


Ha sido un honor en lo profesional haber co-dirigido junto a M Coiras la Tesis Doctoral Alejandro Luna, y un auténtico placer en lo personal compartir estos años contigo. El futuro es tuyo Alex!!. Un lujo haber contado con este tribunal! Fermín Sánchez-Guijo Julio García Suárez Hematología y Hemoterapia RYC


The lymphoma and CTS research fellows Memorial Sloan Kettering Cancer Center 🔬🥼🧪🧑💻#ASH23


Congrats to Roni Shouval on a deeply informative tour of comorbidity indices, and what they do and to not teach us about our transplant candidates.


Esta dedicatoria para todo Hematología y Hemoterapia RYC la comparte nuestra compañera Anabelle Chinea ❤️



Late afternoon coding session Memorial Sloan Kettering Cancer Center with Roni Shouval 💻👾 #shouvallab


Lab night out! Celebrating Alejandro Luna coming departure back to 🇪🇸 Memorial Sloan Kettering Cancer Center


Episode 2: ICAHT Take It Anymore! CAR Hematotoxicity with Kai Rejeski is here! Find us on Apple, Spotify, or wherever you get your podcasts. podcasts.apple.com/us/podcast/chi…



Can’t wait to attend the resistant CML session at #EHA2024. My friend and colleague Valentin Garcia will defend drug therapy against allo-SCT 🥊 Don’t miss it! (on Saturday at 8 am, Hall N105) Hematología y Hemoterapia RYC


🚨 hot off the press 🚨 A (perhaps) underestimated aspect of CAR T-cell therapy: non-relapse mortality. Check out our new meta-analysis on this clinically relevant topic - out today in Nature Medicine ! nature.com/articles/s4159… Let’s take a deeper dive! Start 🧵
